Pandith, A. A., Qasim, I., Zahoor, W., Shah, P., Bhat, A. R., Sanadhya, D., . . . Naikoo, N. A. (2018). Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide). Nature Portfolio.
Style de citation Chicago (17e éd.)Pandith, Arshad A., Iqbal Qasim, Wani Zahoor, Parveen Shah, Abdul R. Bhat, Dheera Sanadhya, Zafar A. Shah, et Niyaz A. Naikoo. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.
Style de citation MLA (8e éd.)Pandith, Arshad A., et al. Concordant Association Validates MGMT Methylation and Protein Expression as Favorable Prognostic Factors in Glioma Patients on Alkylating Chemotherapy (Temozolomide). Nature Portfolio, 2018.